2+ concentrations in astrocytes via A 2a adenosine receptors involving protein kinase A (PKA) activation. The Ca 2+ rise is inhibited by brefeldin A, an inhibitor of vesicular transport; but not by neomycin and U73122, phospholipase C inhibitors; xestospongin, an IP 3 -receptor inhibitor; ryanodine, a ryanodine-receptor inhibitor; TMB-8, an endoplasmic reticulum calcium-release blocker; octanol, a gap-junction inhibitor; or cadmium, a non-selective, calcium-channel blocker. Adenosine stimulates astrocytic glutamate release via an A 2a adenosine receptors / PKA pathway, and the release is inhibited by the vesicular transport inhibitors brefeldin A and bafilomycin A1. A 2a adenosine receptors and the ensuing PKA events, thus, are endowed with vesicular Ca 2+ release from an unknown intracellular calcium store and vesicular glutamate release from astrocytes.
, astrocyte
A new neuromodulatory pathway with a glial contribution mediated via A 2a adenosine receptors Several lines of evidence have pointed to direct communications between neurons and astrocytes. Astrocytes express a wide range of receptors and respond to synaptically released neurotransmitters released from presynaptic terminals (1) . Astrocytes, alternatively, release neurotransmitters in response to an increase in intracellular Ca 2+ concentrations, which in turn stimulates neurons (2 -6) . A low concentration (10 nM) of adenosine facilitates hippocampal neurotransmission, where adenosine does not affect synaptically released glutamate and GABA or postsynaptic glutamatergic and GABAergic conductances (7) . Adenosine, on the other hand, inhibits functions of the astrocytic glutamate transporter GLT-1 and stimulated glutamate release via A 2 adenosine receptors involving protein kinase A (PKA) activation (7) . Those actions could enhance synaptic glutamate concentrations, responsible for the facilitatory action of adenosine on hippocampal neurotransmission. Adenosine, thus, modulates hippocampal neurotransmission by targeting astrocytes.
Intracellular Ca
2+ rise in astrocytes via A 2a adenosine receptors Adenosine (10 nM) increases astrocytic intracellular Ca 2+ concentrations in Ca
2+
-containing and -free extracellular solution, indicating that adenosine stimulates Ca 2+ release from intracellular Ca 2+ stores in astrocytes (7). The Ca 2+ rise is inhibited by 3,7-dimethyl-1-propargylxanthine (DMPX), an antagonist of A 2 adenosine receptors, or H-89, a selective inhibitor of PKA (7). This suggests that the intracellular Ca 2+ rise is regulated via an A 2a adenosine receptors / PKA pathway. In further support of this idea, the A 2 adenosine receptor agonist CGS21680 enhances intracellular Ca 2+ concentrations in astrocytes, and the effect is inhibited by DMPX or H-89 (Fig. 1) . Surprisingly, brefeldin A, an inhibitor of vesicular transport, inhibits the CGS21680 action (Fig. 1) . This, taken together with the fact that the intracellular Ca 2+ rise is not affected by the phospholipase C inhibitors neomycin and U73122, the IP 3 -receptor inhibitor xestospongin, the ryanodine-receptor inhibitor ryanodine, the endoplasmic reticulum (ER) calciumrelease blocker TMB-8, the gap-junction inhibitor *Corresponding author. FAX: +81-798-45-6649 E-mail: tomoyuki@hyo-med.ac.jp octanol, or the non-selective calcium channel blocker cadmium (Fig. 1) , raises the possibility that A 2a adenosine receptors and the ensuing PKA events bear vesicular Ca 2+ release from an as yet unidentified intracellular Ca 2+ store in astrocytes.
Glutamate release from astrocytes via A 2a adenosine receptors
It is shown that intracellular Ca 2+ rise triggers glutamate release from astrocytes (2 -6, 8) . As expected, adenosine causes a 2 -3-fold increase in glutamate release from cultured hippocampal astrocytes from normal rats and mice (7) . A similar increase is obtained with cultured astrocytes from GLT-1 knock-out mice and the glutamate release is not inhibited by the GLT-1 inhibitor dehydrokainic acid or by deleting Na + from extracellular solution (7) . These demonstrate that the glutamate release is not due to reverse transport by transporters including GLT-1. Adenosine-induced glial glutamate release is inhibited by DMPX or H-89, but not by 8-CPT, an agonist of A 1 adenosine receptors (7). Additionally, CGS21680 stimulates astrocytic glutamate release; and the effect is inhibited by DMPX, H-89, or the vesicular transport inhibitors brefeldin A and bafilomycin A1 (Fig. 2) . It is concluded from these results that adenosine stimulates vesicular glutamate release from astrocytes via A 2a adenosine receptor involving PKA activation (Fig. 3) . Astrocytes contain synaptic proteins such as synaptobrevin II, cellubrevin, syntaxin, and SNAP-25 analogue (9 -11) . Then, the next important question as to how PKA interacts with those synaptic proteins awaits resolution.
